Baxter International (BAX) Stock Price, Fundamentals & Analysis

What BAX does

Baxter International (BAX) is a US healthcare stock operating in the Medical Instruments & Supplies industry. Headquartered in Deerfield, United States, the company serves hospitals, nursing homes, dialysis centers, and patients at home through three segments: Medical Products & Therapies, Healthcare Systems & Technologies, and Pharmaceuticals. Its portfolio includes sterile intravenous solutions, infusion systems, parenteral nutrition therapies, inhaled anesthetics, surgical sealants, advanced operating-room equipment, smart bed systems, patient monitoring and diagnostic technologies, and respiratory health devices.

Key numbers explained

• 23.49 USD is the current share price, reflecting what investors pay for one share today.
• The forward P/E ratio of 11.5 divides the share price by expected future earnings; a lower figure often suggests the stock is priced more conservatively relative to earnings expectations.
• Dividend yield of 0.17% shows the annual dividend as a percentage of the share price; it is a measure of cash income relative to the stock's cost.
• Ex-dividend date of 28 aug. 2026 is the cutoff date: buyers on or after this date do not receive the next dividend payment.
• 308% of earnings paid out as dividends means the company distributes more than its net income to shareholders, often drawing on cash reserves or borrowing.
• Beta of 0.6 indicates the stock tends to move less than the overall market; a beta below 1 suggests lower volatility.
• Market cap of 12.14 mld. USD is the total value of all outstanding shares and is used to classify the company's size.
• Revenue growth of 5.3% year over year shows how the company's top line has changed over the trailing twelve months.
• Debt-to-equity ratio of 156.4% compares total debt to shareholders' equity, indicating the company relies more on debt than on equity financing.

Recent news

Recent headlines note that Baxter International (BAX) is being compared to broader market movements, including questions about whether it is underperforming the S&P 500. Other stories highlight strong Q2 growth that led the company to raise its 2026 outlook, even as margin pressure continues, and there is ongoing industry coverage of the drug reconstitution systems market in which Baxter competes alongside peers such as ICU Medical and [B. Braun](/stocks/us/b Braun).

What to watch

Investors tracking Baxter International (BAX) often monitor healthcare spending trends, regulatory changes affecting medical devices and pharmaceuticals, and competitive dynamics within the Medical Instruments & Supplies sector. Because the company is part of the S&P 500, broader index movements and interest-rate shifts can also influence its valuation. For context on peers, investors may compare it with companies like Abbott Laboratories (ABT), Edwards Lifesciences (EW), and Amgen (AMGN).